MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge
Sign Up to like & getrecommendations! Published in 2021 at "npj Vaccines"
DOI: 10.1038/s41541-021-00410-8
Abstract: Numerous vaccine candidates against SARS-CoV-2, the causative agent of the COVID-19 pandemic, are under development. The majority of vaccine candidates to date are designed to induce immune responses against the viral spike (S) protein, although… read more here.
Keywords: sars cov; mva; adult syrian; syrian hamsters ... See more keywords